Literature DB >> 16079479

Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation.

Yoshiko Kawai1, Saburo Taniuchi, Shigeki Okahara, Masuhisa Nakamura, Munekazu Gemba.   

Abstract

Nedaplatin is known to exhibit antitumor activity similar to that of cisplatin. However, concerning side effects, nedaplatin causes renal toxicity less frequently than cisplatin. In this study, we compared the incidence of renal toxicity between cisplatin and nedaplatin by investigating the difference in kidney tissue accumulation. Kidney tissue accumulation of cisplatin administered at 3.75 mg/kg was similar to that of nedaplatin administered at 24 mg/kg. At these doses, the plasma creatinine level and urinary excretion of glucose and N-acetyl-beta-D-glucosaminidase (NAG) similarly increased. There was a correlation between kidney accumulation of cisplatin and nedaplatin and the increases in plasma creatinine level and urinary excretion of NAG. Therefore, our results suggest that nedaplatin less frequently causes renal toxicity in comparison to cisplatin due to lower kidney accumulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079479     DOI: 10.1248/bpb.28.1385

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  23 in total

Review 1.  Chemotherapy-associated renal dysfunction.

Authors:  Vaibhav Sahni; Devasmita Choudhury; Ziauddin Ahmed
Journal:  Nat Rev Nephrol       Date:  2009-06-30       Impact factor: 28.314

2.  A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma.

Authors:  Yi-Fu He; Chu-Shu Ji; Bing Hu; Ping-Sheng Fan; Chang-Lu Hu; Feng-Shou Jiang; Jian Chen; Lei Zhu; Yi-Wei Yao; Wei Wang
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

3.  Experimental verification of age-dependent cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced computed tomography.

Authors:  Atsushi Tachibana; Ayumu Nagasawa; Akihiro Kitamura; Shohei Miyazaki; Kenya Murase
Journal:  Jpn J Radiol       Date:  2010-02-26       Impact factor: 2.374

4.  Pharmacokinetic-Pharmacodynamic Analysis of Cisplatin with Hydration and Mannitol Diuresis: The Contribution of Urine Cisplatin Concentration to Nephrotoxicity.

Authors:  Keizo Fukushima; Akira Okada; Hiroyuki Oe; Mika Hirasaki; Mami Hamori; Asako Nishimura; Nobuhito Shibata; Nobuyuki Sugioka
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

5.  Tubular nephrotoxicity induced by docetaxel in non-small-cell lung cancer patients.

Authors:  Takayuki Takimoto; Tasuku Nakabori; Akio Osa; Satomu Morita; Haruko Terada; Susumu Oseto; Takashi Iwazawa; Kinya Abe
Journal:  Int J Clin Oncol       Date:  2011-08-19       Impact factor: 3.402

6.  Sitagliptin exerts anti-apoptotic effect in nephrotoxicity induced by cisplatin in rats.

Authors:  Rehab S Abdelrahman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-05       Impact factor: 3.000

7.  Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.

Authors:  Pei-Jian Peng; Bao-Jun Lv; Zhi-Hui Wang; Hai Liao; Yu-Meng Liu; Zhong Lin; Yun-Yan Con; Pei-Yu Huang
Journal:  Ther Adv Med Oncol       Date:  2016-11-02       Impact factor: 8.168

8.  Nedaplatin and paclitaxel compared with carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer.

Authors:  Li Ge; Ning Li; Guang-Wen Yuan; Yang-Chun Sun; Ling-Ying Wu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

9.  Concurrent chemoradiotherapy with nedaplatin in patients with stage IIA to IVA cervical carcinoma.

Authors:  Toru Fujioka; Toshiaki Yasuoka; Masae Koizumi; Hiroki Tanaka; Hisashi Hashimoto; Motoo Nabeta; Koji Koizumi; Yuko Matsubara; Katsuyuki Hamada; Keiichi Matsubara; Tomihiro Katayama; Akihiro Nawa
Journal:  Mol Clin Oncol       Date:  2012-09-25

10.  Nedaplatin: a radiosensitizing agent for patients with cervical cancer.

Authors:  Seiji Mabuchi; Tadashi Kimura
Journal:  Chemother Res Pract       Date:  2010-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.